This video will provide general information regarding dementia-related hallucinations and delusions and will discuss a proposed neural pathway that may be associated with them. Additionally, the unmet need for the treatment of dementia-related hallucinations and delusions will be discussed, with a particular focus on the risk/benefit ratio of current atypical antipsychotics. This disease awareness, non-CME video is intended only for US healthcare professionals involved in the management of people with dementia-related hallucinations and delusions and is sponsored by Acadia Pharmaceuticals Inc. This video is not meant to discuss specific treatment options for dementia-related psychosis.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.



Stephen A. Brunton, MD, FAAFP

Executive Vice President for Education
Primary Care Education Consortium
Winnsboro, SC 

Stephen M. Stahl, MD, PhD, D.Sc. (Hon).

Adjunct Clinical Professor, Department of Pharmacy Practice, Roseman University, Palm Springs, CA
Executive Vice President of Education, Primary Care Education Consortium, Charlotte, NC
Executive Director, Editor-in-Chief, Clinical Diabetes, Primary Care Metabolic Group, Charlotte, NC

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.